Astrana Health, Inc. (ASTH) News
Track canonical SquawkNews coverage tagged to ASTH, Astrana Health, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 7 indexed stories across 5 publication days and is ordered by the same first-publication timeline used by LiveCast.
H
Astrana Health Affirms FY2026 Sales Guidance of $3.800B-$4.100B vs $4.004B Est
Astrana Health (NASDAQ: ASTH ) affirms FY2026 sales outlook from $3.800 billion-$4.100 billion to $3.800 billion-$4.100 billion vs $4.004 billion estimate.
LIVE | Sep 23, 2026, 01:34 PM UTC
L
Astrana Health Detects Unusual Activity In Subsidiary Environment - SEC Filing
Astrana Health, Inc. NASDAQ:ASTH
REGULATION | Sep 23, 2026, 12:08 PM UTC
L
OUR NEW SHORT: $ASTH We are short Astrana Health, a value-based care company that has grown rapidly through acquisitions and increasingly complex risk-bearing arrangements. -- GLASSHOUSE RESEARCH
OUR NEW SHORT: $ASTH We are short Astrana Health, a value-based care company that has grown rapidly through acquisitions and increasingly complex risk-bearing arrangements. -- GLASSHOUSE RESEARCH
NEWS | Sep 17, 2026, 01:58 PM UTC
L
Astrana Health Price Target Announced at $53.00/Share by Oppenheimer
Ratings actions from Benzinga
NEWS | Sep 15, 2026, 01:57 PM UTC
H
Astrana Health updates corporate presentation, reiterates FY2026 guidance and $267.5M adj. EBITDA midpoint
Astrana Health updated its corporate presentation highlighting platform scale, FY2026 guidance and a $267.5M adjusted EBITDA midpoint.Key Highlights:Original SEC Filing: Astrana Health, Inc. [ ASTH ] - 8-K - Sep. 15, 202
EARNINGS | Sep 15, 2026, 12:55 PM UTC
L
Truist Securities Maintains Buy on Astrana Health, Raises Price Target to $55
Truist Securities analyst Jailendra Singh maintains Astrana Health (NASDAQ: ASTH ) with a Buy and raises the price target from $47 to $55.
EQUITY | Aug 11, 2026, 05:31 PM UTC
L
Astrana Health Affirms FY2026 Sales Guidance of $3.800B-$4.100B vs $4.001B Est
Astrana Health (NASDAQ: ASTH ) affirms FY2026 sales outlook from $3.800 billion-$4.100 billion to $3.800 billion-$4.100 billion vs $4.001 billion estimate.
EARNINGS | Aug 06, 2026, 08:26 PM UTC